Global Oral Proteins and Peptides Market by Drug Type & Application - Opportunity Analysis & Industry Forecast 2017-2028, With an Expected CAGR of 11.7% - ResearchAndMarkets.com

DUBLIN--()--The "Oral Proteins and Peptides Market by Drug Type and Application : Global Opportunity Analysis and Industry Forecast, 2017-2028" report has been added to ResearchAndMarkets.com's offering.

The global oral proteins and peptides market was valued at $643 million in 2016, and is estimated to reach at $8,233 million by 2028, registering a CAGR of 11.7% from 2022 to 2028.

The peptide and protein therapeutics are an important class of medicines, which are administered through the oral route to treat different diseases, which include gastric, hormonal, and metabolic disorders. These drugs hold significant potential to improve the human health.

Upsurge in collaboration between pharmaceutical companies for drug development and surge in prevalence of chronic diseases are the key factors that augment the growth of the global oral proteins and peptides market. Moreover, rise in geriatric population and improvement in healthcare infrastructure are expected to boost the market growth.

However, low bioavailability of oral proteins and peptides and high cost associated with drug development are some of the factors that restrain the market growth. Conversely, increase in purchasing power of developing countries and rise in R&D activities by pharmaceutical companies are expected to provide new opportunities for market players in the near future.

The oral proteins and peptides market is segmented into drug type, application, and region. By drug type, the market is divided into linaclotide, plecanatide, calcitonin, insulin, and octreotide. By application, it is categorized into gastric & digestive disorders, bone diseases, diabetes, and hormonal disorders. Based on region, it is analyzed across the U.S. and rest of the world.

Companies Mentioned:

  • Allergan plc
  • AstraZeneca plc
  • Biocon Limited
  • Chiasma, Inc.
  • Proxima Concepts Limited
  • Generex Biotechnology Corp.
  • Novo Nordisk A/S
  • Synergy Pharmaceuticals Inc.
  • Tarsa Therapeutics Inc.

Key Topics Covered:

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Oral Proteins And Peptides Market, By Drug Type

Chapter 5: Oral Proteins And Peptides Market, By Application

Chapter 6: Oral Proteins And Peptides Market, By Region

Chapter 7: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/tt449b/global_oral?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery